Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalja Bouwhuis

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Pharmacology|November 2, 2023
Product development and quality of pharmacy compounded chenodeoxycholic acid capsules for Dutch cerebrotendinous xanthomatosis patientsNatalja Bouwhuis, Bart A W Jacobs, E Marleen Kemper
European Journal of Hospital Pharmacy : Science and Practice|March 23, 2026
Limited sample stability of chenodeoxycholic acid in pharmaceutical quality controlNatalja Bouwhuis, Bart A W Jacobs, E Marleen Kemper
Pharmaceutics|March 29, 2023
Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis DefectsYasmin Polak, Bart A W Jacobs, Natalja Bouwhuis, et al.
Pharmaceutics|December 31, 2025
Pharmacokinetic Cross-Over Study of Pharmacy-Compounded Chenodeoxycholic Acid Capsules Compared to Authorized CapsulesNatalja Bouwhuis, Bart A W Jacobs, Soumia Majait, et al.
European Journal of Hospital Pharmacy : Science and Practice|February 26, 2026
Stability study of pharmacy compounded high-dose ambroxol hydrochloride capsules for an n-of-1 clinical trial involving Dutch patients with Gaucher disease type 3Hoang Lan Le, Natalja Bouwhuis, Carla E M Hollak, et al.
Pharmaceutics|April 26, 2025
Product Development of High-Dose Ambroxol HCl Capsules for an n-of-1 Clinical Trial Involving Dutch Patients with Gaucher Disease Type 3Hoang Lan Le, Natalja Bouwhuis, Carla E M Hollak, et al.
Journal of Inherited Metabolic Disease|March 7, 2026
Safety and Effectiveness of Pharmacy Compounded Chenodeoxycholic Acid Capsules for Patients With Cerebrotendinous XanthomatosisNatalja Bouwhuis, Soumia Majait, Yasmin Polak, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 6, 2024
Challenges in the identification and quantification of an unknown impurity in chenodeoxycholic acid drug substanceNatalja Bouwhuis, Yasmin Polak, Anneliene M Schimmel, et al.
Journal for Immunotherapy of Cancer|September 30, 2024
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE studyIdris Bahce, Chris Dickhoff, Famke L Schneiders, et al.
Journal for Immunotherapy of Cancer|June 22, 2026
Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trialEzgi B Ulas, Nora D Purcell, Ilias Houda, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|November 2, 2023
Product development and quality of pharmacy compounded chenodeoxycholic acid capsules for Dutch cerebrotendinous xanthomatosis patientsNatalja Bouwhuis, Bart A W Jacobs, E Marleen Kemper
European Journal of Hospital Pharmacy : Science and Practice|March 23, 2026
Limited sample stability of chenodeoxycholic acid in pharmaceutical quality controlNatalja Bouwhuis, Bart A W Jacobs, E Marleen Kemper
Pharmaceutics|March 29, 2023
Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis DefectsYasmin Polak, Bart A W Jacobs, Natalja Bouwhuis, et al.
Pharmaceutics|December 31, 2025
Pharmacokinetic Cross-Over Study of Pharmacy-Compounded Chenodeoxycholic Acid Capsules Compared to Authorized CapsulesNatalja Bouwhuis, Bart A W Jacobs, Soumia Majait, et al.
European Journal of Hospital Pharmacy : Science and Practice|February 26, 2026
Stability study of pharmacy compounded high-dose ambroxol hydrochloride capsules for an n-of-1 clinical trial involving Dutch patients with Gaucher disease type 3Hoang Lan Le, Natalja Bouwhuis, Carla E M Hollak, et al.
Pharmaceutics|April 26, 2025
Product Development of High-Dose Ambroxol HCl Capsules for an n-of-1 Clinical Trial Involving Dutch Patients with Gaucher Disease Type 3Hoang Lan Le, Natalja Bouwhuis, Carla E M Hollak, et al.
Journal of Inherited Metabolic Disease|March 7, 2026
Safety and Effectiveness of Pharmacy Compounded Chenodeoxycholic Acid Capsules for Patients With Cerebrotendinous XanthomatosisNatalja Bouwhuis, Soumia Majait, Yasmin Polak, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 6, 2024
Challenges in the identification and quantification of an unknown impurity in chenodeoxycholic acid drug substanceNatalja Bouwhuis, Yasmin Polak, Anneliene M Schimmel, et al.
Journal for Immunotherapy of Cancer|September 30, 2024
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE studyIdris Bahce, Chris Dickhoff, Famke L Schneiders, et al.
Journal for Immunotherapy of Cancer|June 22, 2026
Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trialEzgi B Ulas, Nora D Purcell, Ilias Houda, et al.
Pageof 1